Capecitabine Tablet Market Report 2025 (Global Edition)

Global Capecitabine Tablet Market Report 2025 Market Size Split by Indication (Colorectal Cancer, Breast Cancer, Others), by End Users (Professional Hospitals, Homecare, Specialty Clinics, Others), by...

Capecitabine Tablet Market Report Description

We have various report editions of Capecitabine Tablet Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Capecitabine Tablet Market Insights Video

Competitive Landscape of Capecitabine Tablet

The market for capecitabine is fairly competitive and has a large number of primary rivals. The majority of Capecitabine businesses operate in the post-pandemic era with a sense of urgency and a customer-centric mindset. Attempts to lower costs throughout the value chain so that products can be sold at competitive prices. 

• April 2019: Imatinib and Capecitabine, the second and third generic drugs Armas Pharmaceuticals, Inc. released for the US market, were announced with excitement. These items represent Weapons' first dependable oral oncology offerings. Imatinib will be offered in 100mg and 400mg doses, and capecitabine will be offered in 150mg and 500mg doses.

(Source:www.biospace.com/article/releases/armas-pharmaceuticals-expands-generic-portfolio-with-launches-of-capecitabine-and-imatinib/)

Top Companies Market Share in Capecitabine Tablet Industry: (In no particular order of Rank)

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• Bayer AG (Germany)
• Lilly (U.S.)
• Merck & Co.
• Inc. (U.S.)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Lupin (India)
• Alkem Labs Ltd (India)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, North America Capecitabine Tablet Market share was 35% of total market

Several factors led to North America dominating the market and contributing more than 35% of global revenue in 2023, claim Cognitive Market Research. Capecitabine Tablet sales are primarily concentrated in North America. The growing prevalence of diseases including colorectal and colon cancer is responsible for the area's dominance. Rising cancer rates are attributed to a variety of factors, including physical inactivity, obesity, stress, and a sedentary lifestyle. Additionally, a large rise in the elderly population in the US caused by the presence of baby boomers throughout the anticipated era boosts regional revenue. As an outcome, the marketplace is supported by a sizable target market and increasing spending power in the United States. Additionally, the presence of significant producers engaged in cancer clinical studies, such as Roche, Teva, and others, is anticipated to contribute to the significant revenue share of the worldwide capecitabine market.

Asia-Pacific is the second-biggest marketplace for capecitabine when research and development are taken into account. The market for capecitabine is anticipated to expand quickly due to the existence of significant generic pharmaceutical companies in the Asia-Pacific region, as well as increased government activities and special communities.

The current report Scope analyzes Capecitabine Tablet Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

Capecitabine Tablet Market Analysis

Indication Segment Analysis

The breast cancer agent category held the biggest market share in 2023, according to Cognitive Market Research. Healthcare facilities use capecitabine to treat breast cancer that has returned following prior treatment and has progressed to tissues & lymph nodes across the chest, neck, and other areas. And early-stage triple-negative breast cancer is another condition for which capecitabine is used. 

The fastest-growing subsegment in this group is colorectal cancer. The first site of colorectal cancer is the colon or rectum. These cancers may also be referred to as colon or rectal cancer depending on where they develop. Rectal and colon cancer are commonly grouped together due to the parallels in many of their features. The majority of colorectal cancers start as growths on the inner lining of the colon or rectum.

• Colorectal Cancer
• Breast Cancer
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Capecitabine Tablet Industry. Request a Free Sample PDF!

End Users Segment Analysis

In terms of end user, the hospitals sector held the biggest market share in 2023. Numerous international governmental organisations, including the European Union, the United States Food and Drug Administration (FDA), and others have approved the use of capecitabine in the treatment of cancer. Numerous cancer chemotherapy regimens must include capecitabine. As a result, capecitabine is used in hospitals to treat a variety of diseases, such as colorectal cancer, advanced & metastatic breast cancer, and others. This significant factor is propelling market growth on a global scale. 

The sector in this area with the fastest growth rate is speciality centres. A facility and staff that satisfies the minimal requirements defined by the programme and are approved by the board for programme usage in the complete treatment and diagnostic procedures for a particular medical condition are referred to as specialty centres. 

• Professional Hospitals
• Homecare
• Specialty Clinics
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Capecitabine Tablet Drug Type Segment Analysis

The segment's highest share belonged to the generic drug industry. An after-the-active-ingredient medicine is referred to as a generic drug. However, although carrying the same active components as the brand-name treatment, generic medications will be marketed under distinct brand names. The active ingredients in generic medications are of same quality to those in brand-name medications, though, so far as their efficacy is concerned. All medications must abide by the rigid guidelines and oversight of the FDA (Food and Drug Administration) in the US and other akin organisations abroad.

A sizable portion of this market was occupied by the brand-name medicine sector. The name given by the manufacturing company is referred to as the brand name of the medicine. People prefer to purchase the same brand of drugs regardless of price due to their loyalty to and attractiveness to certain brands. 

• Branded 
• Generic

Capecitabine Tablet Distribution Channel Segment Analysis

In this area, the hospital pharmacy industry held the largest proportion. A hospital's department responsible for preparing, compounding, storing, and dispensing inpatient pharmaceuticals is known as the hospital pharmacy. Hospital pharmacy typically carry a wider selection of drugs than would be practical in a community environment, including more specialised and exploratory drugs (drugs that are being researched but have not yet received approval). 

The fastest-growing industry in this section is the online pharmacy industry. A pharmacy that works online and delivers orders to customers via the mail, shipping services, or an online pharmacy web site is known as an online pharmacy, internet pharmacy, or mail-order pharmacy. Online pharmacies include: Pharmacy benefits managers - Organisations in charge of managing corporate prescription drug schemes.

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Author's Detail

Vinayak Bali

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

Catering to tailored needs of clients in Consulting, Business Intelligence, Market Research, Forecasting, Matrix-Modelling, Data Analytics, Competitive Intelligence, Primary research and Consumer Insights.

Author's Conclusion